311 related articles for article (PubMed ID: 30936160)
1. The NOD-
Khalaf OH; Chaki SP; Garcia-Gonzalez DG; Ficht TA; Arenas-Gamboa AM
Infect Immun; 2019 Jun; 87(6):. PubMed ID: 30936160
[TBL] [Abstract][Full Text] [Related]
2. Brucella abortus 2308ΔNodVΔNodW double-mutant is highly attenuated and confers protection against wild-type challenge in BALB/c mice.
Li Z; Wang S; Zhang J; Yang G; Yuan B; Huang J; Han J; Xi L; Xiao Y; Chen C; Zhang H
Microb Pathog; 2017 May; 106():30-39. PubMed ID: 28131952
[TBL] [Abstract][Full Text] [Related]
3. Interaction of Brucella abortus with Osteoclasts: a Step toward Understanding Osteoarticular Brucellosis and Vaccine Safety.
Khalaf OH; Chaki SP; Garcia-Gonzalez DG; Suva LJ; Gaddy D; Arenas-Gamboa AM
Infect Immun; 2020 Mar; 88(4):. PubMed ID: 31932325
[TBL] [Abstract][Full Text] [Related]
4. Booster vaccination with safe, modified, live-attenuated mutants of Brucella abortus strain RB51 vaccine confers protective immunity against virulent strains of B. abortus and Brucella canis in BALB/c mice.
Truong QL; Cho Y; Kim K; Park BK; Hahn TW
Microbiology (Reading); 2015 Nov; 161(11):2137-48. PubMed ID: 26341622
[TBL] [Abstract][Full Text] [Related]
5. Brucella abortusΔcydCΔcydD and ΔcydCΔpurD double-mutants are highly attenuated and confer long-term protective immunity against virulent Brucella abortus.
Truong QL; Cho Y; Park S; Kim K; Hahn TW
Vaccine; 2016 Jan; 34(2):237-244. PubMed ID: 26616550
[TBL] [Abstract][Full Text] [Related]
6. Non-infectious outer membrane vesicles derived from Brucella abortus S19Δper as an alternative acellular vaccine protects mice against virulent challenge.
Solanki KS; Varshney R; Qureshi S; Thomas P; Singh R; Agrawal A; Chaudhuri P
Int Immunopharmacol; 2021 Jan; 90():107148. PubMed ID: 33189614
[TBL] [Abstract][Full Text] [Related]
7. Extended safety and efficacy studies of the attenuated Brucella vaccine candidates 16 M(Delta)vjbR and S19(Delta)vjbR in the immunocompromised IRF-1-/- mouse model.
Arenas-Gamboa AM; Rice-Ficht AC; Fan Y; Kahl-McDonagh MM; Ficht TA
Clin Vaccine Immunol; 2012 Feb; 19(2):249-60. PubMed ID: 22169089
[TBL] [Abstract][Full Text] [Related]
8. DeltaznuADeltapurE Brucella abortus 2308 mutant as a live vaccine candidate.
Yang X; Thornburg T; Walters N; Pascual DW
Vaccine; 2010 Jan; 28(4):1069-74. PubMed ID: 19914192
[TBL] [Abstract][Full Text] [Related]
9. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
[TBL] [Abstract][Full Text] [Related]
11. Epitope-Based Vaccine of a
Oliveira KC; Brancaglion GA; Santos NCM; Araújo LP; Novaes E; Santos RL; Oliveira SC; Corsetti PP; de Almeida LA
Front Immunol; 2021; 12():778475. PubMed ID: 34992597
[No Abstract] [Full Text] [Related]
12. The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB/c mice when delivered in a sustained-release vehicle.
Arenas-Gamboa AM; Ficht TA; Kahl-McDonagh MM; Gomez G; Rice-Ficht AC
Infect Immun; 2009 Feb; 77(2):877-84. PubMed ID: 19047401
[TBL] [Abstract][Full Text] [Related]
13. Intermediate rough Brucella abortus S19Δper mutant is DIVA enable, safe to pregnant guinea pigs and confers protection to mice.
Lalsiamthara J; Gogia N; Goswami TK; Singh RK; Chaudhuri P
Vaccine; 2015 May; 33(22):2577-83. PubMed ID: 25869887
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide as a target for brucellosis vaccine design.
Conde-Álvarez R; Arce-Gorvel V; Gil-Ramírez Y; Iriarte M; Grilló MJ; Gorvel JP; Moriyón I
Microb Pathog; 2013 May; 58():29-34. PubMed ID: 23219811
[TBL] [Abstract][Full Text] [Related]
15. Brucella abortus S19 rfbD mutant is highly attenuated, DIVA enable and confers protection against virulent challenge in mice.
Lalsiamthara J; Kaur G; Gogia N; Ali SA; Goswami TK; Chaudhuri P
Biologicals; 2020 Jan; 63():62-67. PubMed ID: 31843357
[TBL] [Abstract][Full Text] [Related]
16. Protective and therapeutic efficacy study of divalent fusion protein rL7/L12-Omp25 against B. abortus 544 in presence of IFNγ.
Paul S; Peddayelachagiri BV; Nagaraj S; Konduru B; Batra HV
Appl Microbiol Biotechnol; 2018 Oct; 102(20):8895-8907. PubMed ID: 30136204
[TBL] [Abstract][Full Text] [Related]
17. A potent Brucella abortus 2308 Δery live vaccine allows for the differentiation between natural and vaccinated infection.
Zhang J; Yin S; Guo F; Meng R; Chen C; Zhang H; Li Z; Fu Q; Shi H; Hu S; Ni W; Li T; Zhang K
J Microbiol; 2014 Aug; 52(8):681-8. PubMed ID: 24994009
[TBL] [Abstract][Full Text] [Related]
18. Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.
Kahl-McDonagh MM; Arenas-Gamboa AM; Ficht TA
Infect Immun; 2007 Oct; 75(10):4923-32. PubMed ID: 17664263
[TBL] [Abstract][Full Text] [Related]
19. A rapid cycleave PCR method for distinguishing the vaccine strain Brucella abortus A19 in China.
Nan W; Zhang Y; Tan P; Xu Z; Chen Y; Mao K; Chen Y
J Vet Diagn Invest; 2016 May; 28(3):214-8. PubMed ID: 27075847
[TBL] [Abstract][Full Text] [Related]
20. Brucella abortus ΔrpoE1 confers protective immunity against wild type challenge in a mouse model of brucellosis.
Willett JW; Herrou J; Czyz DM; Cheng JX; Crosson S
Vaccine; 2016 Sep; 34(42):5073-5081. PubMed ID: 27591954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
